P. Blomgren

发表

Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation.

S. Viatchenko‐Karpinski, J. Sudhamsu, Xiaowu Chen, 2019, ACS medicinal chemistry letters.

Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability.

Adam R. Johnson, C. Eigenbrot, J. Lubach, 2016, Bioorganic & medicinal chemistry letters.

Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479.

Wen Jiang, R. Devos, J. Symons, 2007, Bioorganic & medicinal chemistry letters.

Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.

Adam R. Johnson, Z. Modrušan, J. DeVoss, 2017, JCI insight.

Efficient scavenging of Ph3P and Ph3P=O with high-loading merrifield resin.

P. Blomgren, B. Lipshutz, 2001, Organic letters.

Biaryls via Suzuki Cross-Couplings Catalyzed by Nickel on Charcoal☆

J. Sclafani, P. Blomgren, B. Lipshutz, 2000 .

Kumada couplings catalyzed by nickel on charcoal (Ni/C)

J. Sclafani, P. Blomgren, B. Lipshutz, 1999 .

Nickel on Charcoal (“Ni/C”): An Expedient and Inexpensive Heterogeneous Catalyst for Cross-Coupling Between Aryl Chlorides and Organometallics. Part 1. Functionalized Organozinc Reagents.

P. Blomgren, B. Lipshutz, 1999 .

Nickel on Charcoal (“Ni/C”): An Expedient and Inexpensive Heterogeneous Catalyst for Cross-Couplings between Aryl Chlorides and Organometallics. I. Functionalized Organozinc Reagents

P. Blomgren, B. Lipshutz, 1999 .

Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties

Adam R. Johnson, C. Eigenbrot, J. Lubach, 2017, ACS medicinal chemistry letters.

Nickel(0)-catalyzed couplings of vinyl- alanes & - zirconocenes with chloromethylated heteroaromatics: A route to E-allylated heterocycles

P. Blomgren, B. Lipshutz, P. Mollard, 1998 .

The Enantioselective Synthesis of anti-β-Hydroxy-α-Amino Acids via the Reaction of Lithium Enolates of Glycine Bearing an Oxazolidine Chiral Auxiliary with Aldehydes

Henry H. Gu, E. Iwanowicz, P. Cheng, 1998 .

Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase.

H. Rong, K. Currie, J. Kropf, 2014, Journal of medicinal chemistry.

Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.

D. Brittelli, R. Desimone, K. Currie, 2009, Bioorganic & medicinal chemistry letters.

Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834.

S. Hymowitz, J. Lubach, K. Reif, 2015, Bioorganic & medicinal chemistry letters.

Synthesis of RNA using 2'-O-DTM protection.

M. Brännvall, M. Kwiatkowski, A. Földesi, 2006, Journal of the American Chemical Society.

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases.

J. Chandrasekhar, Helen Yu, S. Wise, 2020, ACS medicinal chemistry letters.

A simple and convenient one-pot method for the preparation of heteroaryl-2-imidazoles from nitriles

M. Voss, P. Blomgren, Matthew E. Voss, 2008 .

Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase.

H. Rong, K. Currie, J. Kropf, 2014, Journal of medicinal chemistry.

Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.

K. Currie, J. Darrow, D. Pippin, 2009, Bioorganic & medicinal chemistry letters.